Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...

Experts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening side effects found in the existing drugs. Experts at the ongoing ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

KUCHING: Asean member states must work together to reduce the cost of next-generation antiretroviral (ARV) drugs for HIV ...

GENEVA and LONDON, July 30, 2019 /PRNewswire/ -- This year marks the fifth anniversary of the signing of two licensing agreements between ViiV Hea ...

Findings from Kenya by CEMA at the International AIDS Society Conference on HIV ScienceRwanda, July 15, 2025-- The University of Nairobi, Center for Epidemiological Modelling and Analysis (CEMA), has ...

Experts reveal that the new TLD treatment for HIV shows superior effectiveness and fewer side effects compared to the older TLE regimen, making it a significant advancement in HIV care ahead of ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

Vials containing the new HIV combo treatment Cabenuva, which was approved by the U.S. Food and Drug Administration. (ViiV Healthcare) By Associated Press. Jan. 22, 2021 6 AM PT .

The Global Fund announced Wednesday a deal with generic pharmaceutical manufacturers to significantly slash the price of a cutting-edge HIV drug, in a move it said would save lives.

Combination anti-HIV antibody infusions suppress virus for prolonged period. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2022 / 06 / 220601111823.htm.

Novel HIV combination therapies could prevent viral escape and rebound. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2022 / 07 / 220719113442.htm. eLife.